Lymphoma Clinical Trials in Pennsylvania

Showing 601-620 of 668 trials

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00021372

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining paclitaxel and estramustine in treating patients who have relapsed or refractory non-Hodgkin's lymphoma.

Lymphoma

Fox Chase Cancer Center25 participantsStarted Feb 1996

Flemington, New Jersey, United States • Lakewood, New Jersey, United States • Millville, New Jersey, United States +14 more locations

COMPLETEDPhase 395 miles

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00005977

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have non-Hodgkin's lymphoma or acute lymphocytic leukemia.

LeukemiaLymphoma

Children's Oncology Group83 participantsStarted Sep 2000

Birmingham, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +116 more locations

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Lymphoma Trials in Other Cities

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

A Study to Assess AFM13 in Patients With Hodgkin Lymphoma

Other Conditions in Pennsylvania